Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by ventureveston Jul 29, 2010 9:53am
440 Views
Post# 17306432

Reality Check.... #1

Reality Check.... #1Firstly... Linda Bloom is not  worth this  compensation package... From Sedar Filling:

MANAGEMENT CONTRACTS

The Corporation has an employment agreement (the “Bloom Employment Agreement”) with Ms. Lynda

Bloom, whereby Ms. Bloom is employed by the Corporation in her capacity as President and CEO of the

Corporation at an initial base salary of $175,000 per annum, with an annual bonus to be determined by

the Compensation Committee. During the financial year ended August 31, 2009, Ms Bloom took unpaid

vacation days and also forgave $26,250 of salaries which had been accrued but unpaid, resulting in an

annual salary of $144,583 for the financial year ended August 31, 2009. The Corporation has also paid

Ms. Bloom a bonus of $36,900 for the financial year ended August 31, 2009. Ms. Bloom’s salary

and bonus have been included as part of “Annual Compensation – Salary” for Ms. Bloom.

<< Previous
Bullboard Posts
Next >>